Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy
Journal of experimental medicine
Open Access Publication
Rights and Permissions
Chong Zuo, John M. Baer, Brett L. Knolhoff, Jad I. Belle, Xiuting Liu, Angela Alarcon De La Lastra, Christina Fu, Graham D. Hogg, Natalie L. Kingston, Marcus A. Breden, Paarth B. Dodhiawala, Daniel Cui Zhou, Varintra E. Lander, C. Alston James, Li Ding, Kian-Huat Lim, Ryan C. Fields, William G. Hawkins, Jason D. Weber, Guoyan Zhao, David G. DeNardo; Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy. J Exp Med 5 June 2023; 220 (6): e20212062. @2023 Zuo et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20212062. © 2023 Zuo et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
Zuo, Chong; Baer, John M; Knolhoff, Brett L; Belle, Jad I; Liu, Xiuting; Alarcon De La Lastra, Angela; Hogg, Graham D; Kingston, Natalie L; Breden, Marcus A; Dodhiawala, Paarth B; Zhou, Daniel Cui; Lander, Varintra E; James, C Alston; Ding, Li; Lim, Kian-Huat; Fields, Ryan C; Hawkins, William G; Weber, Jason D; Zhao, Guoyan; DeNardo, David G; and et al., "Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy." Journal of experimental medicine. 220, 6. e20212062 (2023).
ICTS (Institute of Clinical and Translational Sciences)
Supplemental material is available for this article at publisher site.